Hermes Medical Solutions receives 510(k) FDA clearance for Affinity
Stockholm – January 17, 2020
Hermes Medical Solutions has received 510(k) FDA clearance for its Affinity TM product. The product has previously been CE-marked and Health Canada (MDD).
Affinity TM is a complete molecular imaging and nuclear medicine viewing and analysis tool based on the latest technologies and incorporating the latest clinical developments. The users will experience more accurate diagnosis capabilities, more diagnostic applications and a simplified personalized workflow.
The intuitive user interface is developed by experts from the gaming industry and revolutionizes the performance and usability to create a completely new experience for clinical software. With ultrafast DICOM loading, crystal clear visualization utilizing Deep Fusion TM technology and AI driven personalized workflows Affinity reduce the time from image to diagnosis.
“Affinity is the next generation of molecular imaging analysis tool, paving the road for theranostics”, says Hermes Medical Solutions´ CEO Tom Francke. “Affinity TM is the most advanced and easiest to use molecular imaging product on the market. It is now both CE-marked and FDA-cleared”.
Contact: Tom Francke, email@example.com